Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of APD-791 with Aspirin and Clopidogrel
NCT02034292Phase 1Terminated
- Sponsor
- Ildong Pharmaceutical Co Ltd
- Start
- Feb 2014
- Primary completion
- Mar 2014
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial of temanogrel in acute coronary syndrome (ACS) (9 arms), sponsored by Ildong Pharmaceutical Co Ltd. Primary endpoint: Safety of APD791. Started Feb 2014; status: terminated.
02
Drugs
temanogrel
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT02034292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02034292.